Ellen M. Ginzler

37.5k total citations · 6 hit papers
98 papers, 9.5k citations indexed

About

Ellen M. Ginzler is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Ellen M. Ginzler has authored 98 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Rheumatology, 35 papers in Immunology and 19 papers in Pathology and Forensic Medicine. Recurrent topics in Ellen M. Ginzler's work include Systemic Lupus Erythematosus Research (84 papers), T-cell and B-cell Immunology (20 papers) and Monoclonal and Polyclonal Antibodies Research (19 papers). Ellen M. Ginzler is often cited by papers focused on Systemic Lupus Erythematosus Research (84 papers), T-cell and B-cell Immunology (20 papers) and Monoclonal and Polyclonal Antibodies Research (19 papers). Ellen M. Ginzler collaborates with scholars based in United States, United Kingdom and Canada. Ellen M. Ginzler's co-authors include Michelle Petri, Joan T. Merrill, Mary Anne Dooley, Gerald B. Appel, Daniel J. Wallace, David Isenberg, Richard Furie, William W. Freimuth, Neil Solomons and Cynthia Aranow and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Ellen M. Ginzler

92 papers receiving 9.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

2011 1.1k citations Richard Furie, Michelle Petri et al. Arthritis & Rheumatism profile →
Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis

2005 766 citations Ellen M. Ginzler, Mary Anne Dooley et al. profile →
Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis

2009 734 citations Gerald B. Appel, Gabriel Contreras et al. Journal of the American Society of Nephrology profile →
The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index in patients with Systemic Lupus Erythematosus

1997 587 citations Ellen M. Ginzler, Caroline Gordon et al. Arthritis & Rheumatism profile →
Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis

2011 421 citations Mary Anne Dooley, David Jayne et al. profile →
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

2021 299 citations Brad H. Rovin, Y K Onno Teng et al. profile →

Peers

Ellen M. Ginzler

RHEUM

IMMUN

RNMI

NEPHR

HEPAT

Chi Chiu Mok China

Joan T. Merrill United States

Guillermo Ruiz‐Irastorza Spain

Richard Furie United States

Rosalind Ramsey‐Goldman United States

Iva Gunnarsson Sweden

Gunnar Sturfelt Sweden

Kenneth Kalunian United States

Cheryl Yarboro United States

Susan Manzi United States

Chi Chiu Mok China

Ellen M. Ginzler

6.3k ×0.8

RHEUM

3.5k ×0.7

IMMUN

1.3k ×0.4

RNMI

1.5k ×0.7

NEPHR

869 ×0.7

HEPAT

Citations per year, relative to Ellen M. Ginzler Ellen M. Ginzler (= 1×) peers Chi Chiu Mok

Countries citing papers authored by Ellen M. Ginzler

Since Specialization

Citations

This map shows the geographic impact of Ellen M. Ginzler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen M. Ginzler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen M. Ginzler more than expected).

Fields of papers citing papers by Ellen M. Ginzler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen M. Ginzler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen M. Ginzler. The network helps show where Ellen M. Ginzler may publish in the future.

Co-authorship network of co-authors of Ellen M. Ginzler

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen M. Ginzler. A scholar is included among the top collaborators of Ellen M. Ginzler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen M. Ginzler. Ellen M. Ginzler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Carlucci, Philip M., Jill P. Buyon, H. Michael Belmont, et al.. (2024). Prevalence of concomitant rheumatologic diseases and autoantibody specificities among racial and ethnic groups in SLE patients. SHILAP Revista de lepidopterología. 4. 1334859–1334859. 3 indexed citations

Berger, Jeffrey S., Allison Guttmann, Jill P. Buyon, et al.. (2024). Prevalence of cardiovascular events in a population-based registry of patients with systemic lupus erythematosus. Arthritis Research & Therapy. 26(1). 160–160. 3 indexed citations

Saxena, Amit, Ellen M. Ginzler, Keisha L. Gibson, et al.. (2023). Safety and Efficacy of Long‐Term Voclosporin Treatment for Lupus Nephritis in the Phase 3 AURORA 2 Clinical Trial. Arthritis & Rheumatology. 76(1). 59–67. 49 indexed citations

Rosenbaum, James T., Karen H. Costenbader, Ellen M. Ginzler, et al.. (2021). Collaboration for the Management of Hydroxychloroquine. Ophthalmology. 128(7). 1115–1116. 2 indexed citations

Wallace, Daniel J., Ellen M. Ginzler, Joan T. Merrill, et al.. (2019). Safety and Efficacy of Belimumab Plus Standard Therapy for Up to Thirteen Years in Patients With Systemic Lupus Erythematosus. Arthritis & Rheumatology. 71(7). 1125–1134. 84 indexed citations

Muslimov, Ilham A., Anna Iacoangeli, Taesun Eom, et al.. (2019). Neuronal BC RNA Transport Impairments Caused by Systemic Lupus Erythematosus Autoantibodies. Journal of Neuroscience. 39(39). 7759–7777. 16 indexed citations

Ginzler, Ellen M., et al.. (2019). Is ethnicity linked to the severity of SLE manifestations?. Nature Reviews Rheumatology. 15(9). 515–516. 9 indexed citations

Ginzler, Ellen M. & Mary Anne Dooley. (2014). Systemic Lupus Erythematosus. Rheumatic Disease Clinics of North America. 40(3). xiii–xiv. 4 indexed citations

Rovin, Brad H., Samir V. Parikh, Lee A. Hebert, et al.. (2012). Lupus Nephritis. Clinical Journal of the American Society of Nephrology. 8(1). 147–153. 37 indexed citations

10.

Merrill, Joan T., Ellen M. Ginzler, Daniel J. Wallace, et al.. (2012). Long‐term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus. Arthritis & Rheumatism. 64(10). 3364–3373. 88 indexed citations

11.

Furie, Richard, Michelle Petri, Daniel J. Wallace, et al.. (2009). Novel evidence‐based systemic lupus erythematosus responder index. Arthritis Care & Research. 61(9). 1143–1151. 341 indexed citations

12.

Isenberg, David, Gerald B. Appel, Gabriel Contreras, et al.. (2009). Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study. Lara D. Veeken. 49(1). 128–140. 233 indexed citations

13.

Appel, Gerald B., Gabriel Contreras, Mary Anne Dooley, et al.. (2009). Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis. Journal of the American Society of Nephrology. 20(5). 1103–1112. 734 indexed citations breakdown →

14.

Radhakrishnan, Jai, Dimitrios-Anestis Moutzouris, Ellen M. Ginzler, et al.. (2009). Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis. Kidney International. 77(2). 152–160. 128 indexed citations

15.

Lee, Susan, et al.. (2007). Increased nitric oxide production by peripheral blood monocytes and selective elevation of serum IgE in patients with systemic lupus erythematosus (SLE). (101.13). The Journal of Immunology. 178(1_Supplement). S203–S203. 1 indexed citations

16.

Ginzler, Ellen M., et al.. (2005). Newer Therapeutic Approaches for Systemic Lupus Erythematosus. Rheumatic Disease Clinics of North America. 31(2). 315–328. 15 indexed citations

17.

Petri, Michelle, Robert G. Lahita, Ronald van Vollenhoven, et al.. (2002). Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: A double‐blind, randomized, placebo‐controlled trial. Arthritis & Rheumatism. 46(7). 1820–1829. 111 indexed citations

18.

Mirotznik, Jerrold, et al.. (1998). Using the Health Belief Model to Explain Clinic Appointment-Keeping for the Management of a Chronic Disease Condition. Journal of Community Health. 23(3). 195–210. 49 indexed citations

19.

Ginzler, Ellen M.. (1991). Clinical manifestations of disease activity, its measurement, and associated morbidity in systemic lupus erythematosus. Current Opinion in Rheumatology. 3(5). 780–788. 5 indexed citations

20.

Ginzler, Ellen M., et al.. (1979). Candida arthritis secondary to repeated intra-articular corticosteroids.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 79(3). 392–4. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact